Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer.
about
Anaphylactic reactions to oligosaccharides in red meat: a syndrome in evolution.Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studiesRole of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis.Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.Kinetic analysis of novel mono- and multivalent VHH-fragments and their application for molecular imaging of brain tumours.Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesOptical imaging predicts tumor response to anti-EGFR therapy.Immune biomarkers of anti-EGFR monoclonal antibody therapySynergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence.Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment.Cetuximab combined with chemotherapy is beneficial for patients with advanced non-small cell lung cancer after EGFR-tyrosine kinase inhibitors failure.PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathwaysMolecular mechanisms of head and neck cancer.Interaction of antibodies with ErbB receptor extracellular regions.A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck.Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium.Cetuximab (erbitux).Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningiomaA rare but severe pulmonary side effect of cetuximab in two patients.Cetuximab: a guide to its use in combination with FOLFIRI in the first-line treatment of metastatic colorectal cancer in the USA.Concurrent chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy (sequential approach) in the management of head and neck cancer.Protein engineering to target complement evasion in cancer.Incidence of cetuximab-related infusion reactions in oncology patients treated at the University of North Carolina Cancer Hospital.Regorafenib: a review of its use in previously treated patients with progressive metastatic colorectal cancer.An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer.Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.More than a headache: a case of cetuximab-induced aseptic meningitis.AKT can modulate the in vitro response of HNSCC cells to irreversible EGFR inhibitors.Effect of radiotherapy on expression of hyaluronan and EGFR and presence of mast cells in squamous cell carcinoma of the head and neck.Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction.Assessment of cetuximab efficacy by bioluminescence monitoring of intracranial glioblastoma xenograft in mouse.Dramatic response to nivolumab in xeroderma pigmentosum skin tumor.Targeting of EGFR and HER2 with therapeutic antibodies and siRNA: a comparative study in glioblastoma cells.Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.
P2860
Q21245667-03BB217B-0916-4681-8328-40AC198F4D2FQ26781698-54A9F515-0104-47B6-B383-DD6609543844Q33599123-C6CFE0A7-0C53-4F62-AC81-E1034B3A7A41Q33893381-AD8F4F38-26F9-4165-98CC-5A6B6059F26AQ34112887-D3D8727B-3F23-4A65-B63E-AA6D62B087CAQ34139691-EACCE07D-76D1-40CE-A0E8-324E619FEF5CQ34581923-D60D661E-5C4A-42C2-9E16-7B400A22AD50Q34723594-68F64B67-5F0C-422B-B45E-B4546392E9B4Q35076330-5D4B4930-7E66-4D3F-8BB5-3CAEE60C5772Q36244369-8737D726-F9F1-4A88-863E-99204D76AEAAQ36245116-49BE7AA4-E332-4F82-A5AE-114A31429DB1Q36317864-6988D14F-D0F5-4656-B2EF-92194DDCD722Q36335893-60F6A660-391C-4CC6-A455-BCE991C9567FQ36545995-36C8C512-B38B-4E4C-BEA4-BE1DC4AD1777Q37159537-338F2B48-3159-43CE-A671-D2148C3189FEQ37320814-87F39B24-9BB1-4DFD-8C66-3AAB0382A489Q37385588-C0AA06C7-C487-4219-9256-2120424D9EFBQ37420570-54DAE0CD-EC5F-4A43-9D13-365FFD5FDFDCQ37570370-DF383976-82EF-4271-8372-DC071370B951Q37659101-8121028C-E2BB-40F0-9602-1BB65C9F19B2Q37694893-9DA324F2-85F7-4B19-BB9D-C50808ED7C61Q37761398-7E070628-9AEA-441F-93AE-E5D8C0CDA9BFQ38030496-7C6D36B6-9D57-452E-BC4F-4F1361B4B29BQ38051281-5EC9841C-E824-436E-B61C-B51245768CF0Q38139996-92715E89-D0BC-46A9-AD26-DE27880147DCQ38163242-DB541552-5177-440E-BF3C-8245647FDE1DQ38163520-50D6F9BF-CD41-492F-B2E0-201C8EFF050AQ38166273-1B33E69B-EC20-4791-AC4D-0207D0716687Q38554714-9DE5FC00-6E8D-48E9-93FC-205959AD05FCQ39020800-E6CEC19B-0B67-4665-97B9-996D6B579AEEQ40156278-C5978051-A44C-45B4-A7D9-4FEF28551503Q41593135-0A72AC9A-6251-4A2A-8793-BDE92834C10DQ42140117-C93E5BD1-67B1-40FA-9675-944C60E83861Q44538149-CEB41C06-2EE4-4750-8BF6-112DDF76555FQ46043347-3015CE65-A42E-4FA9-B3A1-AC1DC63C62BBQ47617121-B11730AC-3390-4F43-9A23-45BA92DA4E40Q51060657-D47A4533-78DC-4002-B057-39D03554DD12Q51698764-CDE31072-CBA5-499C-9659-3B2DB00E307D
P2860
Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cetuximab: a review of its use ...... metastatic colorectal cancer.
@en
Cetuximab: a review of its use ...... metastatic colorectal cancer.
@nl
type
label
Cetuximab: a review of its use ...... metastatic colorectal cancer.
@en
Cetuximab: a review of its use ...... metastatic colorectal cancer.
@nl
prefLabel
Cetuximab: a review of its use ...... metastatic colorectal cancer.
@en
Cetuximab: a review of its use ...... metastatic colorectal cancer.
@nl
P1433
P1476
Cetuximab: a review of its use ...... metastatic colorectal cancer.
@en
P2093
Stephanie K A Blick
P304
P356
10.2165/00003495-200767170-00008
P577
2007-01-01T00:00:00Z
P6179
1034984109